134 related articles for article (PubMed ID: 10331734)
21. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
22. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
23. Single-dose pharmacokinetics of rifapentine in women.
Keung AC; Eller MG; Weir SJ
J Pharmacokinet Biopharm; 1998 Feb; 26(1):75-85. PubMed ID: 9773393
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
25. Rifapentine: its role in the treatment of tuberculosis.
Temple ME; Nahata MC
Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
Cho HY; Moon JD; Lee YB
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
[TBL] [Abstract][Full Text] [Related]
28. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
29. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW;
Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215
[TBL] [Abstract][Full Text] [Related]
30. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.
Svensson EM; Murray S; Karlsson MO; Dooley KE
J Antimicrob Chemother; 2015 Apr; 70(4):1106-14. PubMed ID: 25535219
[TBL] [Abstract][Full Text] [Related]
31. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
Weiner M; Egelund EF; Engle M; Kiser M; Prihoda TJ; Gelfond JA; Mac Kenzie W; Peloquin CA
J Antimicrob Chemother; 2014 Apr; 69(4):1079-85. PubMed ID: 24343893
[TBL] [Abstract][Full Text] [Related]
33. Rifapentine for the treatment of pulmonary tuberculosis.
Munsiff SS; Kambili C; Ahuja SD
Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
37. Non-linear pharmacokinetics of rifampicin in healthy Asian Indian volunteers.
Pargal A; Rani S
Int J Tuberc Lung Dis; 2001 Jan; 5(1):70-9. PubMed ID: 11263520
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients.
Langdon G; Wilkins J; McFadyen L; McIlleron H; Smith P; Simonsson US
Antimicrob Agents Chemother; 2005 Nov; 49(11):4429-36. PubMed ID: 16251279
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.
Savic RM; Lu Y; Bliven-Sizemore E; Weiner M; Nuermberger E; Burman W; Dorman SE; Dooley KE
Antimicrob Agents Chemother; 2014 Jun; 58(6):3035-42. PubMed ID: 24614383
[TBL] [Abstract][Full Text] [Related]
40. Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.
Zvada SP; Van Der Walt JS; Smith PJ; Fourie PB; Roscigno G; Mitchison D; Simonsson US; McIlleron HM
Antimicrob Agents Chemother; 2010 Aug; 54(8):3390-4. PubMed ID: 20516273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
